Ascendiant Downgrades Cytori Therapeutics As ATHENA Trials Are Put On Hold
August 06, 2014 at 11:31 AM EDT
Ascendiant Capital lowered its Buy rating to Hold on Cytori Therapeutics (NASDAQ: CYTX). Ascendiant Capital mentioned that the ...